Physician profile
Jeffrey Todd Smith
NPI 1790744282
$32,716.12
in general payments reported to CMS, 2019-2025
25 companies · $4,984 in 2025
The $4,984 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,149 · 2020: $4,130 · 2021: $8,012 · 2022: $2,812 · 2023: $2,182 · 2024: $6,446 · 2025: $4,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,822 · Travel and Lodging: $5,729 · Entertainment: $61.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,822.41 |
| Travel and Lodging | $5,728.63 |
| Entertainment | $61.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $4,433.07 | 2021 | |
| Globus Medical, INC. | $4,052.15 | 2024-2025 | Excelsius Gps, Xlif, Elsa |
| Spinal Elements, INC. | $3,894.77 | 2021-2025 | |
| Nuvasive, INC. | $3,750.41 | 2019-2023 | Alif, Xlif, Nvm5 |
| Spineology INC. | $3,323.22 | 2021-2023 | Optimesh Expandable Interbody Fusion System |
| Surgalign Spine Technologies, INC. | $2,844.56 | 2019-2022 | |
| Arthrex, INC. | $2,489.80 | 2020-2024 | |
| Prime Surgical, LLC | $2,113.50 | 2020-2024 | |
| Abbott Laboratories | $2,090.20 | 2022-2025 | Proclaim |
| Trackx Technology, INC. | $1,227.27 | 2022-2024 | |
| Si-Bone, INC. | $505.40 | 2025 | |
| Medtronic, INC. | $491.27 | 2021-2025 | Rialto Si Fusion System, Mazor X System, Unid_pass |
| Mirus, LLC | $399.56 | 2021 | |
| Olympus America INC. | $303.22 | 2019-2020 | |
| Providence Medical Technology, INC. | $262.90 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $151.19 | 2025 | Axsos, Pangea |
| Aesculap Implant Systems, LLC | $92.05 | 2019 | |
| Medtronic USA, INC. | $77.74 | 2019-2020 | |
| Intrinsic Therapeutics | $69.23 | 2025 | Barricaid Acd (Annular Closure Device) |
| Zimvie INC. | $46.78 | 2023 | |
| Ermi LLC | $28.18 | 2020 | |
| Smith+Nephew, INC. | $22.88 | 2019 | |
| Bioventus LLC | $18.81 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.20 | 2023 | Xifaxan |
| Endo Pharmaceuticals INC. | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.